Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Invitae Expanded Renal Disease Panel Invitae United States | 693 | 388 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Invitae Corneal Dystrophies Panel Invitae United States | 65 | 33 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics, part of Exact Sciences United States | 346 | 160 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Progressive Renal Disease Panel Invitae United States | 310 | 195 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital United States | 527 | 338 |
|
Invitae Comprehensive Neuropathies Panel Invitae United States | 201 | 96 |
|
PreventionGenetics, part of Exact Sciences United States | 40 | 27 |
|
Familial Amyloidosis (Finnish Type) via the GSN Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Baylor Genetics United States | 842 | 637 |
|
Corneal dystrophy panel. NGS panel of 27 genes. Genologica Medica Spain | 44 | 27 |
|
Genologica Medica Spain | 44 | 19 |
|
Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders Germany | 1 | 1 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 1 | 1 |
|
Amyloidosis: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 8 | 8 |
|
Fulgent Genetics United States | 47 | 24 |
|
Lattice Corneal Dystrophy Type II (GSN Single Gene Test) Fulgent Genetics United States | 1 | 1 |
|
Familial Amyloidosis and Related Disorders , Panel Massive Sequencing (NGS) 8 Genes Reference Laboratory Genetics Spain | 5 | 8 |
|
Corneal Dystrophy , Panel Massive Sequencing (NGS) 18 Genes Reference Laboratory Genetics Spain | 27 | 18 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.